Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy
AUTOR(ES)
Stanulla, Martin
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=32163Documentos Relacionados
- Strength capacity in young patients who are receiving maintenance therapy for acute lymphoblastic leukemia: a case-control study
- Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study
- CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia
- TCRAD rearrangement in B-cell precursor leukemia: an unexpected finding
- Prenatal ultrasound examinations and risk of childhood leukaemia: case-control study